News

The Hidden Gene That Can Collapse Your Lung – And It’s 100x More Common Than We Thought
A gene once believed to be extremely rare may actually be surprisingly common—and capable of quietly raising the risk of ...
What causes lung cancer in non-smokers, as Esther Rantzen shares health update
Dame Esther Rantzen has issued a candid update on her health, following her diagnosis with stage four lung cancer two years ...
pharmaphorum5d
CRUK scientists find new tool to test lung cancer therapies
The team from Cancer Research UK's Manchester Institute says it has created a new in vitro model of lung squamous cell ...
Medscape13d
Biomarkers Offer Clues to Prognoses in Lung Adenocarcinoma
New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...
Healio11d
Smoking cessation, reduction efforts prevent 3.8 million lung cancer deaths since 1970
Cigarette smoking declines over the past several decades prevented an estimated 3.8 million lung cancer deaths, according to ...
American Lung Association12d
South Dakota Lung Cancer Advocate Travels to Washington, D.C. to Share Personal Story with Lawmakers
Sioux Falls resident Janelle Jamtgaard is a lung cancer advocate living with lung cancer. On Monday, April 7, Jamtgaard will travel to Washington, D.C. to meet with her members of Congress as part of ...
European Medical Journal8d
Phase III Lung Cancer Trial Terminated Due to Futility
A phase 3 clinical trial of ociperlimab for advanced non-small cell lung cancer has been halted after early results showed it ...
CURE13d
First-line Rybrevant Combo Extends Survival in Advanced Lung Cancer
First-line Rybrevant plus Lazcluze significantly extended overall survival versus Tagrisso in mutated, advanced or metastatic non-small cell lung cancer.